Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04512846

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Sponsor: Beijing 302 Hospital

View on ClinicalTrials.gov

Summary

The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.

Official title: Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)

Key Details

Gender

All

Age Range

30 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2020-08-01

Completion Date

2026-08-30

Last Updated

2023-06-27

Healthy Volunteers

No

Locations (1)

Beijing 302 hospital

Beijing, China